201 related articles for article (PubMed ID: 34480042)
1. Epigallocatechin gallate inhibits release of extracellular vesicles from platelets without inhibiting phosphatidylserine exposure.
Millington-Burgess SL; Harper MT
Sci Rep; 2021 Sep; 11(1):17678. PubMed ID: 34480042
[TBL] [Abstract][Full Text] [Related]
2. Maintaining flippase activity in procoagulant platelets is a novel approach to reducing thrombin generation.
Millington-Burgess SL; Harper MT
J Thromb Haemost; 2022 Apr; 20(4):989-995. PubMed ID: 35034417
[TBL] [Abstract][Full Text] [Related]
3. Persistence of procoagulant surface expression on activated human platelets: involvement of apoptosis and aminophospholipid translocase activity.
Leung R; Gwozdz AM; Wang H; Bang KW; Packham MA; Freedman J; Rand ML
J Thromb Haemost; 2007 Mar; 5(3):560-70. PubMed ID: 17155950
[TBL] [Abstract][Full Text] [Related]
4. Randomized controlled trial protocol to investigate the antiplatelet therapy effect on extracellular vesicles (AFFECT EV) in acute myocardial infarction.
Gasecka A; Nieuwland R; Budnik M; Dignat-George F; Eyileten C; Harrison P; Huczek Z; Kapłon-Cieślicka A; Lacroix R; Opolski G; Pluta K; van der Pol E; Postuła M; Leroyer A; Siljander P; Sturk A; Filipiak KJ
Platelets; 2020; 31(1):26-32. PubMed ID: 30585111
[TBL] [Abstract][Full Text] [Related]
5. Activated scramblase and inhibited aminophospholipid translocase cause phosphatidylserine exposure in a distinct platelet fraction.
Wolfs JL; Comfurius P; Rasmussen JT; Keuren JF; Lindhout T; Zwaal RF; Bevers EM
Cell Mol Life Sci; 2005 Jul; 62(13):1514-25. PubMed ID: 15971000
[TBL] [Abstract][Full Text] [Related]
6. Diannexin, an annexin A5 homodimer, binds phosphatidylserine with high affinity and is a potent inhibitor of platelet-mediated events during thrombus formation.
Rand ML; Wang H; Pluthero FG; Stafford AR; Ni R; Vaezzadeh N; Allison AC; Kahr WH; Weitz JI; Gross PL
J Thromb Haemost; 2012 Jun; 10(6):1109-19. PubMed ID: 22463102
[TBL] [Abstract][Full Text] [Related]
7. Vincristine induces procoagulant activity of the human lymphoblastic leukemia cell line Jurkat through the release of extracellular vesicles.
Pluchart C; Poitevin G; Colinart-Thomas M; Guimard G; Audonnet S; Terryn C; Nguyen P
J Thromb Thrombolysis; 2019 Aug; 48(2):195-202. PubMed ID: 31175530
[TBL] [Abstract][Full Text] [Related]
8. Effect of MSCs and MSC-Derived Extracellular Vesicles on Human Blood Coagulation.
Silachev DN; Goryunov KV; Shpilyuk MA; Beznoschenko OS; Morozova NY; Kraevaya EE; Popkov VA; Pevzner IB; Zorova LD; Evtushenko EA; Starodubtseva NL; Kononikhin AS; Bugrova AE; Evtushenko EG; Plotnikov EY; Zorov DB; Sukhikh GT
Cells; 2019 Mar; 8(3):. PubMed ID: 30893822
[TBL] [Abstract][Full Text] [Related]
9. Coagulation factors bound to procoagulant platelets concentrate in cap structures to promote clotting.
Podoplelova NA; Sveshnikova AN; Kotova YN; Eckly A; Receveur N; Nechipurenko DY; Obydennyi SI; Kireev II; Gachet C; Ataullakhanov FI; Mangin PH; Panteleev MA
Blood; 2016 Sep; 128(13):1745-55. PubMed ID: 27432876
[TBL] [Abstract][Full Text] [Related]
10. The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib.
Connor DE; Exner T; Ma DD; Joseph JE
Thromb Haemost; 2010 May; 103(5):1044-52. PubMed ID: 20390225
[TBL] [Abstract][Full Text] [Related]
11. Lipid rafts are essential for release of phosphatidylserine-exposing extracellular vesicles from platelets.
Wei H; Malcor JM; Harper MT
Sci Rep; 2018 Jul; 8(1):9987. PubMed ID: 29968812
[TBL] [Abstract][Full Text] [Related]
12. ABT-737 Triggers Caspase-Dependent Inhibition of Platelet Procoagulant Extracellular Vesicle Release during Apoptosis and Secondary Necrosis In Vitro.
Wei H; Harper MT
Thromb Haemost; 2019 Oct; 119(10):1665-1674. PubMed ID: 31493778
[TBL] [Abstract][Full Text] [Related]
13. Evidence that polyphenols do not inhibit the phospholipid scramblase TMEM16F.
Le T; Le SC; Zhang Y; Liang P; Yang H
J Biol Chem; 2020 Aug; 295(35):12537-12544. PubMed ID: 32709749
[TBL] [Abstract][Full Text] [Related]
14. Vitamin E inhibition on platelet procoagulant activity: involvement of aminophospholipid translocase activity.
Kim JE; Han M; Hanl KS; Kim HK
Thromb Res; 2011 May; 127(5):435-42. PubMed ID: 21296386
[TBL] [Abstract][Full Text] [Related]
15. Platelet phosphatidylserine exposure and procoagulant activity in clotting whole blood--different effects of collagen, TRAP and calcium ionophore A23187.
Ramström S; Rånby M; Lindahl TL
Thromb Haemost; 2003 Jan; 89(1):132-41. PubMed ID: 12540963
[TBL] [Abstract][Full Text] [Related]
16. Effect of osmotic shock and urea on phosphatidylserine scrambling in thrombocyte cell membranes.
Gatidis S; Borst O; Föller M; Lang F
Am J Physiol Cell Physiol; 2010 Jul; 299(1):C111-8. PubMed ID: 20237147
[TBL] [Abstract][Full Text] [Related]
17. 2-Aminoethoxydiphenylborate (2-APB) inhibits release of phosphatidylserine-exposing extracellular vesicles from platelets.
Wei H; Davies JE; Harper MT
Cell Death Discov; 2020; 6():10. PubMed ID: 32140260
[TBL] [Abstract][Full Text] [Related]
18. Annexin V, the regulator of phosphatidylserine-catalyzed inflammation and coagulation during apoptosis.
Reutelingsperger CP; van Heerde WL
Cell Mol Life Sci; 1997 Jun; 53(6):527-32. PubMed ID: 9230931
[TBL] [Abstract][Full Text] [Related]
19. FVIII binding to PS membranes differs in the activated and non-activated form and can be shielded by annexin A5.
Engelke H; Lippok S; Dorn I; Netz RR; Rädler JO
J Phys Chem B; 2011 Nov; 115(44):12963-70. PubMed ID: 21954889
[TBL] [Abstract][Full Text] [Related]
20. Lysophosphatidic acid-induced pro-thrombotic phosphatidylserine exposure and ionophore-induced microvesiculation is mediated by the scramblase TMEM16F in erythrocytes.
Öhlinger T; Müllner EW; Fritz M; Sauer T; Werning M; Baron DM; Salzer U
Blood Cells Mol Dis; 2020 Jul; 83():102426. PubMed ID: 32222693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
